94
Views
2
CrossRef citations to date
0
Altmetric
Review

Management of cancer pain: 1. Wider implications of orthodox analgesics

, , , , , & show all
Pages 49-58 | Published online: 07 Jan 2014

References

  • BrayFJemalAGreyNFerlayJFormanDGlobal cancer transitions according to the Human Development Index (2008–2030): a population-based studyLancet Oncol201213879080122658655
  • JemalACenterMMDeSantisCWardEMGlobal patterns of cancer incidence and mortality rates and trendsCancer Epidemiol Biomarkers Prev20101981893190720647400
  • MundyGRMetastasis to bone: causes, consequences and therapeutic opportunitiesNat Rev Cancer2002258459312154351
  • PantelKBrakenhoffRHDissecting the metastatic cascadeNat Rev Cancer2011444845615170447
  • WilliamsAC de CGesslerSEmpathy in cancer painPaceJABellRFKalsoEASoyannwoOACancer Pain: From Molecules to SufferingWashington, DCInternational Association for the Study of Pain2010 chapter 16
  • RipamontiCLongoMCancer pain syndromes and pharmacotherapy of cancer painArch Oncol2004123168170
  • PaiceJAFerrellBThe management of cancer painCA Cancer J Clin201161315718221543825
  • SabistonCMBrunetJBurkeSPain, movement, and mind: does physical activity mediate the relationship between pain and mental health among survivors of breast cancer?Clin J Pain201228648949522673481
  • AnandUMechanisms and management of cancer painAlisonMRThe Cancer Handbook2nd edChichester, UKJohn Wiley & Sons2007
  • TheriaultRLTheriaultRLBiology of bone metastasesCancer Control20121929210122487971
  • GreenspanJDCraftRMLeRescheLConsensus Working Group of the Sex, Gender, and Pain SIG of the IASPStudying sex and gender differences in pain and analgesia: a consensus reportPain2007132Suppl 1S26S4517964077
  • FallonMWhen morphine does not workSupport Care Cancer20081677177518274786
  • PortenoyRKAhmedEKeilsonYYCancer pain management: use of acetaminophen and nonsteroidal anti-inflammatory drugsUpToDate51201218
  • CostaEGuidottiAMaoCCSuriaANew concepts on the mechanism of action of benzodiazepinesLife Sci197517167185169445
  • DworkinRHBackonjaMRowbothamMCAdvances in neuropathic pain: diagnosis, mechanisms, and treatment recommendationsArch Neurol2003601524153414623723
  • HendrichJVan MinhATHeblichFPharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentinProc Natl Acad Sci U S A20081053628363318299583
  • GilronIGabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directionsCurr Opin Anaesthesiol20072045647217873599
  • PortenoyRKGanae-MotanEDAllendeSNabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trialJ Pain201213543844922483680
  • LeeMCPlonerMWiechKAmygdala activity contributes to the dissociative effect of cannabis on pain perceptionPain2013154112413423273106
  • National Institute for Health and Clinical ExcellenceOpioids in Palliative Care: Safe and Effective Prescribing of Strong Opioids for Pain in Palliative Care of Adults. Clinical Guideline 140 Available from: http://publications.nice.org.uk/opioids-in-palliative-care-safe-and-effective-prescribing-of-strong-opioids-for-pain-in-palliative-cg140Accessed August 23, 2013
  • ChernyN2001Strategies to manage the adverse effects of oral morphine: an evidence based reportJournal of Clinical Oncology1925422554 Cited in Uma Anand. Mechanisms and Management of Cancer Pain. The Cancer Handbook, 2nd Edition. Edited by Malcolm R Alison. 2007 John Wiley & Sons, Ltd11331334
  • SalminenEKSilvoniemiMSyrjänenKKaasaSKlokeMKlepstadPOpioids in pain management of mesothelioma and lung cancer patientsActa Oncol2013521303723025295
  • WallaceERidleyJBrysonJMakEZimmermannCAddition of methadone to another opioid in the management of moderate to severe cancer pain: a case seriesJ Palliat Med201316330530923391350
  • BullochMNHutchisonAMFentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer painExpert Rev Clin Pharmacol20136192223272789
  • EscobarYMañasAJuliáJOptimal management of breakthrough cancer pain (BCP)Clin Transl Oncol Epub12212012
  • JandhyalaRFullartonJRBennettMIEfficacy of rapid-onset oral fentanyl formulations vs oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trialsJ Pain Symptom Manage212013pii S0885–3924(12)00815–00819
  • ZhuYLSongGHLiuDQMulticenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patientsChin J Cancer Res201123431732223359267
  • CleelandCSBodyJJStopeckAPain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acidCancer2013119483283822951813
  • LussierDHuskeyAGPortenoyRKAdjuvant analgesics in cancer pain managementOncologist2004957159115477643
  • Vargas-ShafferGIs the WHO analgesic ladder still valid? Twenty-four years of experienceCan Fam Physician201056651451720547511
  • GröschSMaierTJSchiffmannSGeisslingerGReview: Cyclooxygenase-2 (COX-2) – independent anticarcinogenic effects of selective COX-2 inhibitorsJ Nat Cancer Inst2006981173674716757698
  • Garcia RodriguezLACea-SorianoLTacconelliSPatrignaniPCoxibs: pharmacology, toxicity and efficacy in cancer clinical trialsRecent Results Cancer Res2013191679322893200
  • AlgraAMRothwellPMEffects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trialsLancet Oncol201213551852722440112
  • RothwellPMWilsonMPriceJFBelchJFFMeadesTWMehtaZEffect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsLancet20123791591160122440947
  • RothwellPMPriceJFFowkesFGRShort-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsLancet Oncol201237916021612
  • BosettiCRosatoVGallusSLa VecchiaCAspirin and urologic cancer risk: an updateNat Rev Urol20129210211022270135
  • WalterRBMilanoFBraskyTMWhiteELong-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the Prospective Vitamins and Lifestyle (VITAL) studyJ Clin Oncol201129172424243121555699
  • ChoueiriTKJeYChoEAnalgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studiesInt J Cancer Epub272013
  • RobertsSSMoriMPatteePGABAergic system gene expression predicts clinical outcome in patients with neuroblastomaJ Clin Oncol2004224127413415483022
  • TakeharaAHosokawaMEguchiHGamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor P subunitCancer Res2007679704971217942900
  • AzumaHInamotoTSakamotoTGamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanismCancer Res2003638090809614678958
  • TakeharaAHosokawaMEguchiHγ-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor π subunitCancer Res2007679704971217942900
  • OrtegaAA new role for GABA: inhibition of tumor cell migrationTrends Pharmacol Sci20032415115412706998
  • JohnsonSKDennisRABaroneGWLampsLWHaunRSDifferential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarrayMol Carcinog2006451181482716865675
  • MaemuraKShiraishiNSakagamiKProliferative effects of γ-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1/2 activationJ Gastroenterol Hepatol20092468869619032445
  • ZafrakasMChorovicerMKlamanISystematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissueInt J Cancer200611861453145916187283
  • Al-WadeiHAAl-WadeiMHUllahMFSchullerHMCelecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed micePLoS One201278e4337622916251
  • LöscherWRogawskiMAHow theories evolved concerning the mechanism of action of barbituratesEpilepsia201253Suppl 8122523205959
  • MiyawakiIMoriyasuMFunabashiHYasubaMMatsuokaNMechanism of clobazam-induced thyroidal oncogenesis in male ratsToxicol Lett200314529130114580900
  • PottegårdAFriisSAndersenMHallasJUse of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control studyBr J Clin Pharmacol20137551356136423043261
  • XieJLiYHuangYAnesthetic pentobarbital inhibits proliferation and migration of malignant glioma cellsCancer Lett20092821354219346066
  • DethloffLBarrBBesterveltLBuleraSSiglerRLaGattutaMGabapentin-induced mitogenic activity in rat pancreatic acinar cellsToxicol Sci200055525910788559
  • HenleFLeemhuisJFischerCGabapentin-lactam induces dendritic filopodia and motility in cultured hippocampal neuronsJ Pharmacol Exp Ther200631918119116844845
  • SiglerREGoughAWDe La IglesiaFAPancreatic acinar cell neoplasia in male Wistar rats following 2 years of gabapentin exposureToxicology1995981–373827740556
  • FriedmanGDUdaltsovaNChanJQuesenberryCPJrHabelLAScreening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screenedCancer Causes Control200920101821183519582585
  • CriswellKACookJCMorseDPregabalin induces hepatic hypoxia and increases endothelial cell proliferation in mice, a process inhibited by dietary vitamin E supplementationToxicol Sci2012128425622539613
  • PeggDBleavinsMHermanJHemangiosarcoma in mice administered pregabalin: analysis of genotoxicity, tumor incidence, and tumor geneticsToxicol Sci201212892122539615
  • CriswellKAWojcinskiZPeggDKey components of the mode of action for hemangiosarcoma induction in pregabalin-treated mice: evidence of increased bicarbonate, dysregulated erythropoiesis, macrophage activation, and increased angiogenic growth factors in mice but not in ratsToxicol Sci2012128224122539625
  • CriswellKACookJCWojcinskiZMode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevanceToxicol Sci2012128577122539620
  • CarriotFSascoAJCannabis and cancerRev Epidemiol Sante Publique20004847348311084527
  • Lozano-OndouaANHanlonKESymons-LiguoriAMDisease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonistsJ Bone Miner Res20132819210722903605
  • GuptaKKshirsagarSChangLMorphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growthCancer Res2002624491449812154060
  • QinYChenJLiLExogenous morphine inhibits human gastric cancer MGC-803 cell growth by cell cycle arrest and apoptosis inductionAsian Pac J Cancer Prev20121341377138222799335
  • GongLDongCOuyangWQinQRegulatory T cells: a possible promising approach to cancer recurrence induced by morphineMed Hypotheses201380330831023313332
  • QinYLiLChenJFentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in vitroOncol Res2012202–3616923193912
  • ShakeriRMalekzadehREtemadiAOpium; an emerging risk factor for gastric adenocarcinomaInt J Cancer2013133245546123319416
  • GachKWyrębskaAFichnaJJaneckaAThe role of morphine in regulation of cancer cell growthNaunyn Schmiedebergs Arch Pharmacol2011384322123021800094
  • AfsharimaniBCabotPParatMOMorphine and tumor growth and metastasisCancer Metastasis Rev20113022523821267766
  • WoodJNIon channels in analgesia researchHandb Exp Pharmacol200717732935817087129
  • VinkSAlewoodPFTargeting voltage-gated calcium channels: developments in peptide and small molecule inhibitors for the treatment of neuropathic painBr J Pharmacol201216797098922725651
  • LiuMWoodJNThe roles of sodium channels in nociception: implications for mechanisms of neuropathic painPain Med201112Suppl 3S93S9921752183
  • PannerAWursterRDT-type calcium channels and tumor proliferationCell Calcium20064025325916765439
  • FraserSPDissJKChioniAMVoltage-gated sodium channel expression and potentiation of human breast cancer metastasisClin Cancer Res2005115381538916061851
  • OnkalRDjamgozMBMolecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancerEur J Pharmacol200962520621919835862
  • PremkumarLSAboojMTRP channels and analgesiaLife Sci2013928–941542422910182
  • Ouadid-AhidouchHDhennin-DuthilleIGautierMSevestreHAhidouchATRP channels: diagnostic markers and therapeutic targets for breast cancer?Trends Mol Med201319211712423253476
  • MagniGCerutiSP2Y purinergic receptors: new targets for analgesic and antimigraine drugsBiochem Pharmacol201385446647723146663
  • NorthRAJarvisMFP2X Receptors as drug targetsMol Pharmacol201383475976923253448
  • KłopockaWKorczyńskiJPomorskiPCytoskeleton and nucleotide signaling in glioma C6 cellsAdv Exp Med Biol201398610311922879066
  • BraganholEWinkMRLenzGBattastiniAMPurinergic signaling in glioma progressionAdv Exp Med Biol20139868110222879065
  • WatsonJJAllenSJDawbarnDTargeting nerve growth factor in pain: what is the therapeutic potential?BioDrugs20082234935918998753
  • BrackenburyWJDjamgozMBNerve growth factor enhances voltage-gated Na+ channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell lineJ Cell Physiol200721060260817149708
  • VigneaultLTurgeonAFCôtéDPerioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trialsCan J Anaesth2011581223721061107
  • SnyderGLGreenbergSEffect of anaesthetic technique and other perioperative factors on cancer recurrenceBr J Anaesth2010105210611520627881
  • BorsookDA future without chronic pain: neuroscience and clinical research. CerebrumMay201220127